Cancer News and Research

Latest Cancer News and Research

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Low-dose CT lung cancer screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.

13 Sep 2021

Research suggests current smokers not at excess risk of SARS-CoV-2 infection

Now, a new study published on the bioRxiv* preprint server investigates this relationship further and suggests that current smoking is not associated with a higher incidence of SARS-CoV-2 infection.

13 Sep 2021

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).

13 Sep 2021

World-first 3D scanning technology could enable earlier detection of skin cancer

Queenslanders could have skin cancer diagnosed earlier using world-first 3D scanning technology with the launch of the Australian Cancer Research Foundation Australian Centre of Excellence in Melanoma Imaging and Diagnosis.

13 Sep 2021

Adequate communication and support needed for children of cancer patients, research suggests

The announcement of a cancer diagnosis abruptly and durably alters the course of daily life - not just for the person receiving it, but also for their family.

13 Sep 2021

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Nearly two-thirds of thoracic oncologists surveyed indicated they used telehealth tools for the first time during the COVID-19 pandemic, according to a report issued at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival outcomes.

12 Sep 2021

Lung cancer patients report high anxiety levels and experience treatment delays due to the pandemic

Patients coping with lung cancer and treated in one hospital in Mexico reported high levels of anxiety and saw their treatment delayed or due to the COVID-19 pandemic, according to a study presented today at the IASLC World Conference on Lung Cancer.

12 Sep 2021

Study shows how oncology practices changed after durvalumab approval for unresectable stage III NSCLC patients

A study presented today at the IASLC 2021 World Conference on Lung Cancer suggests how oncology practices in the United States changed after 2018, when durvalumab became available for patients with unresectable Stage III non-small cell lung cancer.

12 Sep 2021

Survey: Less than half of community oncologists use biomarker testing to guide lung cancer care

Less than half of community oncologists surveyed indicated that they use biomarker testing to guide patient discussions compared to 73% of academic clinicians, according to a report issued today at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.

12 Sep 2021

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Treatment with atezolizumab plus carboplatin and pemetrexed was safe and yielded promising brain progression-free survival in patients with nonsquamous non-small cell lung cancer with untreated and asymptomatic brain metastases.

12 Sep 2021

First rat model recapitulates all disabling alterations experienced by patients with Morquio A disease

A research team from the Universitat Autònoma de Barcelona has generated the first rat model recapitulating all disabling alterations experienced by patients with Mucopolysaccharidosis type IVA, also known as Morquio A disease.

12 Sep 2021

Enhanced recovery after surgery program helps reduce opioid prescriptions after lung surgery

Lung surgery patients who utilize a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program require fewer opioid prescriptions when discharged and this effect was sustained over the 4-year study period, according to research presented today at the 18th Annual Perioperative and Critical Care Conference from The Society of Thoracic Surgeons.

10 Sep 2021

Tumor-related risk factors affect conversion of active surveillance to treatment for prostate cancer

For men with "low-risk" prostate cancer initially managed with active surveillance, cancer-related factors such as tumor grade and size are key risk factors for conversion to active treatment, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association.

10 Sep 2021

New center at UC San Diego to study the effects of antibiotics on mother’s milk and infant health

More than 70 percent of breastfeeding women take some form of medication, but 90 percent of those medications are not appropriately labeled for pregnant or lactating women.

10 Sep 2021

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients.

10 Sep 2021

Researchers identify mechanism behind structural birth defects in fetuses of mothers with diabetes

More than 3 million women of birthing age in the U.S. and 60 million in the world have diabetes - a disease that occurs when blood sugar is too high.

10 Sep 2021

‘Luckiest man alive’: Why 9/11 first responders’ outlooks may improve even as physical health fails

Ray Pfeifer and Luis Alvarez's names are on the federal 9/11 legislation that establishes benefits for first responders. Both men fought to make Congress pass it while they were dying of cancer — and they had another thing in common. In spite of it all, they were content.

10 Sep 2021

Cancer News and Research

Latest Cancer News and Research

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Research suggests current smokers not at excess risk of SARS-CoV-2 infection

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

World-first 3D scanning technology could enable earlier detection of skin cancer

Adequate communication and support needed for children of cancer patients, research suggests

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Lung cancer patients report high anxiety levels and experience treatment delays due to the pandemic

Study shows how oncology practices changed after durvalumab approval for unresectable stage III NSCLC patients

Survey: Less than half of community oncologists use biomarker testing to guide lung cancer care

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

First rat model recapitulates all disabling alterations experienced by patients with Morquio A disease

Enhanced recovery after surgery program helps reduce opioid prescriptions after lung surgery

Tumor-related risk factors affect conversion of active surveillance to treatment for prostate cancer

New center at UC San Diego to study the effects of antibiotics on mother’s milk and infant health

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

Researchers identify mechanism behind structural birth defects in fetuses of mothers with diabetes

‘Luckiest man alive’: Why 9/11 first responders’ outlooks may improve even as physical health fails

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in